CHS INC - CHSINC 7.1 PERP (CHSCN) Stock Fundamental Analysis
USA - NASDAQ:CHSCN - US12542R5063
25.24 USD
-0.05 (-0.2%)
CHSCN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 86 industry peers in the Food Products industry. CHSCN has a medium profitability rating, but doesn't score so well on its financial health evaluation. CHSCN does not seem to be growing, but still is valued expensively. Finally CHSCN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year CHSCN had a positive cash flow from operations.
Each year in the past 5 years CHSCN has been profitable.
Each year in the past 5 years CHSCN had a positive operating cash flow.
1.2 Ratios
CHSCN has a Return On Assets of 2.61%. This is comparable to the rest of the industry: CHSCN outperforms 56.98% of its industry peers.
CHSCN has a Return On Equity (4.76%) which is in line with its industry peers.
With a Return On Invested Capital value of 0.05%, CHSCN perfoms like the industry average, outperforming 40.70% of the companies in the same industry.
CHSCN had an Average Return On Invested Capital over the past 3 years of 6.11%. This is significantly below the industry average of 28.75%.
The last Return On Invested Capital (0.05%) for CHSCN is well below the 3 year average (6.11%), which needs to be investigated, but indicates that CHSCN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.61% | ||
| ROE | 4.76% | ||
| ROIC | 0.05% |
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
1.3 Margins
CHSCN has a Profit Margin (1.42%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CHSCN has grown nicely.
The Operating Margin of CHSCN (0.02%) is comparable to the rest of the industry.
CHSCN's Operating Margin has declined in the last couple of years.
CHSCN has a Gross Margin of 2.99%. This is amonst the worse of the industry: CHSCN underperforms 86.05% of its industry peers.
CHSCN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.02% | ||
| PM (TTM) | 1.42% | ||
| GM | 2.99% |
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHSCN is still creating some value.
Compared to 1 year ago, CHSCN has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.22 indicates that CHSCN is not a great score, but indicates only limited risk for bankruptcy at the moment.
CHSCN's Altman-Z score of 2.22 is in line compared to the rest of the industry. CHSCN outperforms 51.16% of its industry peers.
CHSCN has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
CHSCN has a better Debt to Equity ratio (0.34) than 61.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.22 |
ROIC/WACC0.01
WACC4.69%
2.3 Liquidity
A Current Ratio of 1.40 indicates that CHSCN should not have too much problems paying its short term obligations.
CHSCN's Current ratio of 1.40 is in line compared to the rest of the industry. CHSCN outperforms 44.19% of its industry peers.
CHSCN has a Quick Ratio of 1.40. This is a bad value and indicates that CHSCN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CHSCN (0.86) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
The Revenue has decreased by -8.96% in the past year.
CHSCN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.24% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CHSCN is valued cheaply inside the industry as 91.86% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.76 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 7.33%, CHSCN is a good candidate for dividend investing.
CHSCN's Dividend Yield is rather good when compared to the industry average which is at 5.10. CHSCN pays more dividend than 90.70% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, CHSCN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.33% |
5.2 History
CHSCN has been paying a dividend for at least 10 years, so it has a reliable track record.
CHSCN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years10
5.3 Sustainability
32.94% of the earnings are spent on dividend by CHSCN. This is a low number and sustainable payout ratio.
DP32.94%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:CHSCN (10/27/2025, 2:04:51 PM)
25.24
-0.05 (-0.2%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners11.67%
Inst Owner Change1043.08%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap309.69M
Revenue(TTM)36.03B
Net Income(TTM)513.00M
Analysts0
Price TargetN/A
Short Float %0.06%
Short Ratio0.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.33% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP32.94%
Div Incr Years0
Div Non Decr Years10
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | 0.65 | ||
| P/B | 0.03 | ||
| P/tB | 0.03 | ||
| EV/EBITDA | 3.76 |
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-26.32
FCFYN/A
OCF(TTM)38.96
OCFY154.35%
SpS2936.43
BVpS878.97
TBVpS878.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.61% | ||
| ROE | 4.76% | ||
| ROCE | 0.07% | ||
| ROIC | 0.05% | ||
| ROICexc | 0.05% | ||
| ROICexgc | 0.05% | ||
| OM | 0.02% | ||
| PM (TTM) | 1.42% | ||
| GM | 2.99% | ||
| FCFM | N/A |
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
ROICexc(3y)6.66%
ROICexc(5y)4.61%
ROICexgc(3y)6.79%
ROICexgc(5y)4.69%
ROCE(3y)8.06%
ROCE(5y)5.71%
ROICexgc growth 3Y38.36%
ROICexgc growth 5Y-3.28%
ROICexc growth 3Y37.82%
ROICexc growth 5Y-3.23%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
F-Score3
Asset Turnover1.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.94 | ||
| Cap/Depr | 131.31% | ||
| Cap/Sales | 2.22% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 77.22% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 2.22 |
F-Score3
WACC4.69%
ROIC/WACC0.01
Cap/Depr(3y)104.21%
Cap/Depr(5y)89.6%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.27%
Profit Quality(3y)93.36%
Profit Quality(5y)103.6%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-98.83%
EBIT growth 3Y41.53%
EBIT growth 5Y-2.03%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-109.49%
FCF growth 3Y1.79%
FCF growth 5Y-7.81%
OCF growth 1Y-87.82%
OCF growth 3Y18.88%
OCF growth 5Y2.23%
CHS INC - CHSINC 7.1 PERP / CHSCN FAQ
What is the ChartMill fundamental rating of CHS INC - CHSINC 7.1 PERP (CHSCN) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHSCN.
Can you provide the valuation status for CHS INC - CHSINC 7.1 PERP?
ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 7.1 PERP (CHSCN). This can be considered as Overvalued.
What is the profitability of CHSCN stock?
CHS INC - CHSINC 7.1 PERP (CHSCN) has a profitability rating of 4 / 10.
What is the financial health of CHS INC - CHSINC 7.1 PERP (CHSCN) stock?
The financial health rating of CHS INC - CHSINC 7.1 PERP (CHSCN) is 3 / 10.